News
-
-
PRESS RELEASE
Disclosure of the number of shares and the total number of voting rights as of 31 May 2024
Lhyfe discloses total shares and voting rights as of 31 May 2024 in compliance with AMF regulations. The green hydrogen producer aims to facilitate energy transition in industry and transport sectors -
-
-
-
-
-
-
-
PRESS RELEASE
Lhyfe and Swiss Steel Group subsidiary Ugitech sign an MoU to decarbonise the steelmaker's operations using green hydrogen
Lhyfe and Ugitech sign MoU to create green hydrogen production unit at Ugitech's site in Savoie, France, aiming to decarbonise steel operations and local mobility, contributing to a sustainable winter tourism model in the French Alps
![Accesswire](/assets/images/accesswire-inline.png)
-
University of York Chooses Alces Flight to Boost Sustainable Research
-
Alset Capital Inc. Announces AI GPU Contract with a $91.7M Option Signed by Investee Company Cedarcross
-
Ivanhoe Electric Clarifies Certain Misleading Media Headlines Regarding Its Recent Registration Statement Filing
-
FE Battery Metals Announces Positive Laboratory Results Producing Lithium Carbonate Grades Exceeding 99% Purity
-
SouthGobi Announces Update on Mongolia Tax Audit
![EQS Group](/assets/images/eqs-group.png)
-
Dr Ingo Mantzke has resigned as Chairman of the Advisory Board of Swiss Merchant Group AG
-
Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy
-
MGI – Media and Games Invest SE held its Annual General Meeting
-
Mililk® now available at Penny
-
TUI AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
![Les Echos](/assets/images/les-echos.png)
-
Moody’s reaffirms « A1 » Outlook Stable rating of CNP Assurances SA
-
EURAZEO OPENS AN OFFICE IN TOKYO, FURTHER EXTENDING ITS INTERNATIONAL REACH
-
imerys-12-06-2024-implementation-of-the-share-buyback-program
-
COGELEC : Statement on the total number of shares and voting rights.
-
Biophytis announces the successful industrial transfer of BIO101 (20-hydroxyecdysone) production by its service provider Seqens